Your browser doesn't support javascript.
loading
Quantitative comparison of the neutralizing capacity, immunogenicity and cross-reactivity of anti-TNF-α biologicals and an Infliximab-biosimilar.
Buurman, D J; Blokzijl, T; Festen, E A M; Pham, B T; Faber, K N; Brouwer, E; Dijkstra, G.
Afiliación
  • Buurman DJ; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Blokzijl T; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Festen EAM; University of Groningen, University Medical Center Groningen, Department of Laboratory Medicine, Groningen, The Netherlands.
  • Pham BT; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Faber KN; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Brouwer E; Department of Gastroenterology and Hepatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Dijkstra G; Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
PLoS One ; 13(12): e0208922, 2018.
Article en En | MEDLINE | ID: mdl-30533022

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Factor de Necrosis Tumoral alfa / Biosimilares Farmacéuticos Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2018 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades Inflamatorias del Intestino / Factor de Necrosis Tumoral alfa / Biosimilares Farmacéuticos Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2018 Tipo del documento: Article